adp-a2m4cd8,nivolumab
bms,adaptimmune therapeutics
['surpass', 'adaptimmune', '$adap']
#adaptimmune reports positive data in its #surpass trial outlines plans for advanced clinical development in multiple #magea4 positive #solidtumors #esmo22 $adap 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.